The fund has the mandate to invest in four sector focused areas Healthcare, Life Sciences, Performance Materials and New Businesses, in alignment with the strategic interests of Merck KGaA, Darmstadt, Germany’s business areas, though formally separated by a “Chinese Wall”. The total volume of the corporate venture fund is € 300 million.
We invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes.
The Healthcare team also manages the Entrepreneur Partnership Program which was established to support the creation of spin-offs from Merck KGaA, Darmstadt, Germany and the Israel Bioincubator, which is focused on pre-seed and seed opportunities coming out of Israel.
The Israel Bioincubator is a strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. Launched in 2011 to offers invest in biomedical innovation in Israel, the Bioincubator both seed financing and access to dedicated laboratory facilities within our Israel based R&D center.
The Life Science Team invests in areas of strategic value to the life science division of Merck KGaA, Darmstadt, Germany.
We invest globally in emerging life science companies that develop products, services and or technologies that have the potential to make research and biotech production easier, faster, more successful and enhance customer service. The Life Science team manages helps driving better solutions for our customers.
The Performance Materials Fund is the strategic, corporate venture arm of the performance materials division of Merck KGaA, Darmstadt, Germany.
We invest globally in emerging performance materials companies that develop high-tech chemicals for sophisticated applications. Specialty chemicals, such as liquid crystals for displays, pigments for coating and cosmetics, or high-tech materials for the electronics industry. The Performance Materials team helps driving better solutions for our customers.
The New Businesses Fund is the strategic, corporate venture arm of Merck KGaA, Darmstadt, Germany.
We invest globally in companies that pursue interdisciplinary approaches and have new ideas to provide the Merck KGaA, Darmstadt, Germany Group with opportunities that go beyond the its existing businesses. The New Businesses team aims to commercialize innovative ideas into possible future markets.
